1 November 2017

Arix Bioscience to present at two investor conferences in November

 

LONDON, 1 November 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience") a global healthcare and life science company supporting medical innovation, will present at two investor conferences in November:                                      

  • Stifel 2017 Healthcare Conference on November 15, 2017 at 11:40 a.m. ET at the Lotte New York Palace Hotel.  Jonathan Peacock, Chairman, will make the presentation, and will participate in one-on-one investor meetings at the conference on 14 and 15 November. 
  • Jefferies 2017 Global Healthcare Conference on 16 November, at 1:20 p.m. GMT at the Waldorf Hilton in London.  Joe Anderson, CEO, will make the presentation and will participate in one-on-one investor meetings at the conference during the course of the day.

 For both conferences, audio webcasts and the investor presentation will be available on Arix’s website at https://arixbioscience.com/presentations on the days of the events.  Webcast replays will be available following the live presentation.

 

For more information, please contact:

Arix Bioscience plc

Matthew Cole, Communications Director

+44 (0) 20 7290 1065

 

Consilium Strategic Communications

Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan

+44 (0)20 3709 5700

arix@consilium-comms.com

 

About Arix Bioscience plc

Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.

 


Back to previous page